Albert, Matthew
Delgado-Herrera, Leticia
Paruch, Jennifer
Gerritsen-van Schieveen, Pauline
Kishimoto, Tomoyoshi
Takusagawa, Shin
Cai, Na
Fengler, John
Raizer, Jeffrey
Funding for this research was provided by:
Astellas Pharma, Inc.
Article History
Received: 28 October 2022
Accepted: 1 June 2023
First Online: 20 July 2023
Declarations
:
: Dr. Matthew Albert received consulting fees/research support from Astellas; Dr. Pauline Gerritsen-van Schieveen, Dr. Na Cai, Dr. Jeffrey Raizer, and Ms. Leticia Delgado-Herrera were employees of Astellas at the time of the study; Dr. Shin Takusagawa and Mr. Tomoyoshi Kishimoto are employees/stockholders of Astellas. Ms. Leticia Delgado-Herrera and Dr. Shin Takusagawa have a patent pending for pharmaceutical composition for imaging; Mr. John Fengler is an employee/stockholder and has patents planned, issued, or pending with Stryker; Dr. Jennifer Paruch has no conflicts of interest or financial ties to disclose.